JPT Peptide Technologies is a DIN ISO 9001:2015 certified provider of innovative high quality peptide-based products and services such as clinical grade peptides pools, custom peptides, peptide pools, stable isotope-labeled peptides and many more. JPT has developed a portfolio of proprietary technologies and a series of unique products which support its customers worldwide. Additionally, JPT is actively involved in R&D partnerships and contract research projects.
JPT's scientific focus is:
Cellular Therapy Immunotherapy
Development of immune monitoring tools diagnostics
Vaccine target discovery
Biomarker quantification by targeted proteomics
Please visit us: https://www.jpt.com/
| Company: | JPT Peptide Technologies GmbH | ||
| Headquarters Address: | Volmerstrasse 5 (UTZ) | ||
| D-12489 Berlin | |||
| Germany | |||
| Main Telephone: | +49-30-6392-5500 | ||
| Website: | www.jpt.com | ||
| Type of Organization: | GmbH | ||
| Industry: | Biotechnology | ||
| Key Executives: | CEO: Holger Wenschuh | ||
| Marketing Sales | |||
| Contact: | Astrid Cortes | ||
| Phone: | +49 30 6392 5500 | ||
| Email: | cortes@jpt.com |
View source version on businesswire.com: https://www.businesswire.com/news/home/20120203005007/en/
